Elicio Therapeutics, Inc. · NASDAQ:ELTX
Moti Investments LLC reported a 6.10% stake in Elicio Therapeutics, Inc. (Schedule 13G)
Event Jul 1, 2026 · Filed Jul 16, 2026
Moti Investments LLC reported a 6.10% stake in Elicio Therapeutics, Inc., 1,408,892 shares, as a passive investor on Jul 1, 2026. Filed Jul 16, 2026 (Schedule 13G).
- Stake
- 6.10%
- Shares
- 1,408,892
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Moti Investments LLC | 6.10% | 1,408,892 |
Source
Related
- Elicio Therapeutics, Inc.
- Moti Investments LLC
- Elicio Therapeutics, Inc. shareholders
- Schedule 13G/A · Knoll Capital Management, LLC · Jul 8, 2026
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · Oct 7, 2025
- Schedule 13D/A · Gkcc, LLC · Jun 4, 2025
- Schedule 13G/A · Actyus Private Equity SGIIC, S.A. · May 14, 2025
- Schedule 13D/A · Chudnovsky Yekaterina · Mar 7, 2025